Clinical Trial Update: A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial compared the pharmacokinetics, pharmacodynamics, and safety of UI058 and UIC202004 in healthy subjects; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• UI058
• UIC202004

Snippet

Sponsor: Korea United Pharm. Inc. | Conditions: GERD | Phase 1 | Status: COMPLETED